# Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section

> **NCT07550413** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Pak Emirates Military Hospital** · enrollment: 182 (estimated)

## Conditions studied

- Post Partum Haemorrhage
- Cesarean Section Surgery

## Interventions

- **DRUG:** Calcium Chloride
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07550413
- **Lead sponsor:** Pak Emirates Military Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 182 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07550413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07550413, "Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07550413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*